Clinical Trials Directory

Trials / Completed

CompletedNCT07206680

Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
55 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.

Detailed description

Based on the occurrence of side effects caused by conventional medication for prolonged employment, dermatologists and patients show solicitude for multifaceted effective methods to control the chronic and relapsing nature of neurodermatitis. Although new modalities are continuously coming up for pruritus, there remains a great gap for providing symptom relief. Furthermore, there is a lack in the quantitative knowledge and information in the published studies about benefits of shockwave therapy on the treatment of pruritus in neurodermatitis patients. So, this study is designed to outline the therapeutic efficacy of shockwave therapy on the treatment of pruritus in neurodermatitis patients.

Conditions

Interventions

TypeNameDescription
DEVICEShockwave therapyThe procedures for Extracorporeal Shockwave Therapy (ESWT) involve several steps. First, the patient is positioned comfortably, and the physiotherapist explains the treatment procedure. Before the session begins, the device cables are checked for proper functioning. The shockwave type used is Non-Focused/Radial, with a treatment duration not exceeding 10 minutes. The frequency is set at 4 Hz, and the intensity ranges from 0.05 to 0.20 mJ/mm². Each session involves a total of 1000 to 2000 shocks. The treatment consists of four sessions, each held once a week.
DRUGEmollients & corticosteroidsPatients in both groups will receive emollients \& corticosteroids for one month.

Timeline

Start date
2024-12-15
Primary completion
2025-09-15
Completion
2025-10-25
First posted
2025-10-03
Last updated
2026-03-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07206680. Inclusion in this directory is not an endorsement.